ICU Medical Revenue 2010-2024 | ICUI
ICU Medical revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
ICU Medical Annual Revenue (Millions of US $) |
2024 |
$2,382 |
2023 |
$2,259 |
2022 |
$2,280 |
2021 |
$1,316 |
2020 |
$1,271 |
2019 |
$1,266 |
2018 |
$1,400 |
2017 |
$1,293 |
2016 |
$379 |
2015 |
$342 |
2014 |
$309 |
2013 |
$314 |
2012 |
$317 |
2011 |
$302 |
2010 |
$283 |
2009 |
$229 |
ICU Medical Quarterly Revenue (Millions of US $) |
2024-12-31 |
$630 |
2024-09-30 |
$589 |
2024-06-30 |
$596 |
2024-03-31 |
$567 |
2023-12-31 |
$588 |
2023-09-30 |
$553 |
2023-06-30 |
$549 |
2023-03-31 |
$569 |
2022-12-31 |
$578 |
2022-09-30 |
$598 |
2022-06-30 |
$561 |
2022-03-31 |
$543 |
2021-12-31 |
$341 |
2021-09-30 |
$336 |
2021-06-30 |
$322 |
2021-03-31 |
$318 |
2020-12-31 |
$320 |
2020-09-30 |
$319 |
2020-06-30 |
$303 |
2020-03-31 |
$329 |
2019-12-31 |
$316 |
2019-09-30 |
$307 |
2019-06-30 |
$312 |
2019-03-31 |
$331 |
2018-12-31 |
$340 |
2018-09-30 |
$327 |
2018-06-30 |
$360 |
2018-03-31 |
$372 |
2017-12-31 |
$370 |
2017-09-30 |
$343 |
2017-06-30 |
$332 |
2017-03-31 |
$248 |
2016-12-31 |
$96 |
2016-09-30 |
$97 |
2016-06-30 |
$97 |
2016-03-31 |
$90 |
2015-12-31 |
$90 |
2015-09-30 |
$86 |
2015-06-30 |
$84 |
2015-03-31 |
$81 |
2014-12-31 |
$80 |
2014-09-30 |
$77 |
2014-06-30 |
$79 |
2014-03-31 |
$73 |
2013-12-31 |
$78 |
2013-09-30 |
$83 |
2013-06-30 |
$79 |
2013-03-31 |
$74 |
2012-12-31 |
$83 |
2012-09-30 |
$81 |
2012-06-30 |
$77 |
2012-03-31 |
$76 |
2011-12-31 |
$76 |
2011-09-30 |
$76 |
2011-06-30 |
$78 |
2011-03-31 |
$71 |
2010-12-31 |
$74 |
2010-09-30 |
$76 |
2010-06-30 |
$69 |
2010-03-31 |
$64 |
2009-12-31 |
$67 |
2009-09-30 |
$54 |
2009-06-30 |
$53 |
2009-03-31 |
$54 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$3.486B |
$2.382B |
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
|